Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study evaluaTing intRacranial effIcacy of JDQ443 in patiEnts With KRAS G12C+ NSCLC and bRain Metastases

NCT05999357 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT05999357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05999357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study evaluaTing intRacranial effIcacy of JDQ443 in patiEnts With KRAS G12C+ NSCLC and bRain Metastases
Lead sponsor
Maastricht University Medical Center
Phase
Phase 2
Overall status
Withdrawn
Start date
April 15, 2024
Completion date
August 31, 2028
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult, kras g12c, non small cell lung cancer metastatic